Investor Presentaiton

"Type 1 Use Regulations" and "Biological Diversity Risk Assessment Report" 1. Content of the Use 2. Method of the Use III. Information concerning the Use of living modified organisms 3. Method of collecting information by person who wishes to obtain approval after the start of Type 1 Use 4. Emergency Measures which should be taken to prevent Adverse Effects on Biological Diversity in case Adverse Effects on Biological Diversity could arise 5. The result of Use in laboratory or Use in an environment similar to that in which Type 1 Use is intended 6. Information obtained from use abroad

View entire presentation